Case Study: Granules India Limited achieves real-time cost visibility and smarter decision-making with SAP HANA

How Do You Achieve Healthy Growth in the Competitive Pharmaceuticals Market to Bring Generic Medicine to the Masses

Granules India Limited, a 30‑year‑old manufacturer of high‑volume generic medicines operating across 75+ countries with eight plants, sought to expand into active pharmaceutical ingredients and contract manufacturing while protecting thin margins. The company faced limited visibility into manufacturing costs and heavy reliance on manual processes, which hindered its ability to evaluate profitability and execute aggressive growth targets.

Working with IBM Services, Granules deployed SAP S/4HANA with the SAP Fiori user experience on the SAP HANA platform, giving managers real‑time dashboards and detailed profitability breakdowns by product, plant, line of business, and region. The solution standardized and automated processes, accelerated reporting and financial consolidation, and put actionable cost insights at users’ fingertips—enabling data‑driven decisions, supporting a projected ~25% growth within 24 months, and helping Granules stay competitive in low‑margin markets.

Granules India Limited

Ganesh Karuppannan

CFO